HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Paul A Brink Selected Research

Proteins (Proteins, Gene)

9/2011Genetic variation in angiotensin II type 2 receptor gene influences extent of left ventricular hypertrophy in hypertrophic cardiomyopathy independent of blood pressure.
8/2008Genetic variation in angiotensin-converting enzyme 2 gene is associated with extent of left ventricular hypertrophy in hypertrophic cardiomyopathy.
5/2007Long-term follow-up of R403WMYH7 and R92WTNNT2 HCM families: mutations determine left ventricular dimensions but not wall thickness during disease progression.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Paul A Brink Research Topics

Disease

5Hypertrophic Cardiomyopathy (Hypertrophic Obstructive Cardiomyopathy)
09/2011 - 05/2007
3Long QT Syndrome
08/2016 - 04/2004
2Heart Diseases (Heart Disease)
11/2022 - 09/2011
2Hypertension (High Blood Pressure)
11/2022 - 01/2019
2Hypertrophy
09/2011 - 03/2008
2Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left)
09/2011 - 08/2008
2Cardiovascular Diseases (Cardiovascular Disease)
09/2010 - 03/2008
1Atrial Fibrillation
11/2022
1Romano-Ward Syndrome
12/2021
1Heart Arrest (Cardiac Arrest)
09/2010
1Cardiac Sudden Death (Sudden Cardiac Arrest)
11/2009
1Fetal Distress
10/2006
1Cardiac Arrhythmias (Arrythmia)
04/2004
1Syncope (Fainting)
04/2004

Drug/Important Bio-Agent (IBA)

3Proteins (Proteins, Gene)FDA Link
09/2011 - 05/2007
2salicylhydroxamic acid (SHAM)IBA
11/2022 - 01/2019
23' Untranslated Regions (3' UTR)IBA
08/2016 - 09/2011
2Troponin T (Troponin T1)IBA
11/2009 - 03/2008
2Ventricular MyosinsIBA
11/2009 - 03/2008
1DiureticsIBA
11/2022
1Antihypertensive Agents (Antihypertensives)IBA
11/2022
1Syntex adjuvant formulationIBA
11/2022
1Adenosine Monophosphate (AMP)IBA
12/2021
1Cyclic AMP-Dependent Protein Kinases (cAMP-Dependent Protein Kinase)IBA
12/2021
1AngiotensinsIBA
09/2011
1Type 2 Angiotensin ReceptorIBA
09/2011
1Myosins (Myosin)IBA
11/2009
1Angiotensin-Converting Enzyme 2IBA
08/2008
1Adrenergic beta-Antagonists (beta-Adrenergic Blocking Agents)IBA
03/2008

Therapy/Procedure

2Denervation
11/2022 - 01/2019
2Therapeutics
09/2010 - 10/2006
1Catheters
11/2022
1Implantable Defibrillators (Implantable Cardioverter-Defibrillator)
09/2010
1Cesarean Section (Caesarean Section)
10/2006
1Defibrillators (Defibrillator)
04/2004
1Sympathectomy (Sympathectomies)
04/2004